Indian Observers

Top Menu

  • Facebook
  • Twitter
  • Youtube
  • Medium

Main Menu

  • Home
  • Top News
  • National
  • Politics
  • Business
  • Technology
  • Sports
  • Entertainment
  • Facebook
  • Twitter
  • Youtube
  • Medium

logo

Indian Observers

  • Home
  • Top News
  • National
  • Politics
  • Business
  • Technology
  • Sports
  • Entertainment
  • Indian Extended Hand Over Vaccines To Neighbours Hurts Chinese Ego

  • Sherlyn Chopra demands for a public apology, says Sajid Khan is a ‘habitual offender’

  • Serum Institute of India building catches fire, five dead, vaccine facility remains unaffected

  • Reliance-Future deal gets clearance from Sebi

  • Indian startups to receive Antler investments worth $100 million

National
Home›National›COVID-19: PM Modi reviews India’s vaccination strategy

COVID-19: PM Modi reviews India’s vaccination strategy

By Staff Writer
November 23, 2020
94
0
India's vaccination strategy

India’s vaccination strategy: As the number of Coronavirus cases continues to surge across various states in India, Prime Minister Narendra Modi on Friday held a virtual meeting with top officials to review the vaccination strategy of the country and efforts needed to make the vaccine accessible to the public.

Taking to Twitter, PM Modi stated that key issues related to the development of the COVID-19 vaccine, regulatory approvals and procurement strategy were discussed during the meeting with a number of senior officials, including members of the government’s think-tank NITI Aayog. In addition, he also reviewed other issues including the prioritisation of the population groups in the vaccination strategy, reaching out to healthcare workers, installation of vaccinators and tech platform for rolling out the vaccine among the masses.

Various drug companies are working across the world to develop a potential vaccine to combat the COVID-19 virus. A number of frontrunners are showing encouraging results in their advanced stages of trials after reporting over 90 percent effectiveness. 

The Modi government recently issued an official statement, stating that five vaccine candidates are in advanced stages of development in India, out of which four are in Phase II-III trials and one is in Phase I-II of clinical trials. The statement also noted that several countries such as Qatar, Bangladesh, Bhutan, Myanmar, Bahrain, Switzerland, South Korea and Austria have shown keen interest in collaborating with India to develop the vaccine to fight COVID-19 and distribute them among the masses.

During the meeting, PM Modi also reviewed various aspects of emergency use authorisation, manufacture and procurement of medicine. In a bid to administer the vaccine, officials are creating a database of healthcare and frontline workers, augmenting cold chains and procuring needles, syringes among other equipment. The National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) has consulted with state governments to implement the vaccination process for priority groups in the first phase.

As soon as the results of the Phase III trials will arrive, regulators will swiftly examine the vaccines for authorising emergency use. The government has allotted Rs 900 aid to assist research and development of vaccines. In India, indigenous Coronavirus vaccine Covaxin is entering Phase III human trials. Serum Institute of India (SII) CEO Adar Poonawalla has also confirmed that the Oxford AstraZeneca COVID-19 vaccine will be made available by February 2021 for priority use for healthcare workers and elderly people, while for the general public, it will be available by April 2021. 

The Centre has also developed the Covid app aimed at streamlining all necessary data and information as part of India’s vaccine rollout including procurement, distribution, storage and scheduling doses. 

Meanwhile, a number of state governments have re-implemented strict restrictions and night curfew measures in a bid to contain the spread of the COVID-19 virus.

TagsCoronavirus PandemicCovaxinCovid appCovid-19 vaccineIndia vaccine strategyModi governmentNEGVACNiti AayogPfizerPM Modivaccine trials
Previous Article

Potential Covid-19 vaccines and the ideal candidate ...

Next Article

India’s high performance athletics coach resigns ahead ...

Related articles More from author

  • Covaxin phase 1 trials
    Coronavirus

    Covid-19 vaccine tracking: Covaxin phase 1 trials show promising results

    December 17, 2020
    By Dr Neha Mathur
  • Phase III clinical trials
    Coronavirus

    COVID-19 vaccine tracking: Phase III clinical trials commence for Bharat Biotech’s COVAXIN

    November 18, 2020
    By Dr Neha Mathur
  • Vaccination against coronavirus
    Coronavirus

    PM Modi launched the largest vaccination against coronavirus today

    January 16, 2021
    By Divya
  • WHO chief thanks PM Modi
    Coronavirus

    WHO chief thanks PM Modi for commitment towards fighting coronavirus

    November 12, 2020
    By Divya
  • External Affairs Minister S Jaishankar
    Politics

    EAM of India, US, Australia, and Japan will meet in Oct to discuss post-coronavirus international order

    October 1, 2020
    By india_observers
  • Narendra Modi during the meeting with CM
    Coronavirus

    PM Modi holds meeting with CMs of 7 states/UTs worst-hit by COVID-19

    September 24, 2020
    By Staff Writer

You might be interested

  • Maharashtra-seeks-doctors-from-Kerala
    CoronavirusTop News

    Maharashtra continues to reel under COVID, seeks doctors from Kerala

  • UAE_Eithad_Covid19_Aid
    CoronavirusInternationalTop News

    COVID-19: UAE Humanitarian Assistance and Support During Global Crisis

  • HCQ-Tablet
    CoronavirusTop News

    ICMR recommends use of HCQ as prophylactic against COVID-19

Technology

Indian startups to receive Antler investments worth $100 million

New year has brought in encouraging news for Indian startups as Antler, the global early-stage Venture Capital (VC) fund announced its plans of investing $100 million in the tech startups ...
  • Nazara

    India’s tech IPO boom is facilitated by game start-up Nazara

    By Dr Neha Mathur
    January 18, 2021
logo

Follow Us

Sitemap
Contact Us

  • Latest Posts

  • Indian Extended Hand Over Vaccines

    Indian Extended Hand Over Vaccines To Neighbours Hurts Chinese Ego

    By Uttara J Malhotra
    January 22, 2021
  • Sherlyn Chopra demands for a public apology

    Sherlyn Chopra demands for a public apology, says Sajid Khan is a ‘habitual offender’

    By Divya
    January 22, 2021
  • Serum Institute of India building catches fire

    Serum Institute of India building catches fire, five dead, vaccine facility remains unaffected

    By Dr Neha Mathur
    January 22, 2021

Trending this Week

  • January 22, 2021

    Serum Institute of India building catches fire, five dead, vaccine facility remains unaffected

  • January 21, 2021

    Palanisawmi says met Modi and Shah, to discuss TN growth plan, not politics

  • January 19, 2021

    China has constructed a village in Arunachal Pradesh: Report

© Copyright 2020 - India Observers.